Abbott LaboratoriesABT

Is ABT cheap right now? Every multiple below is scored against its own 10-year range, not a sector average.

$104.57+1.93 (+1.88%)24:00 UTC
NYSEHealthcareDividend King

Company snapshot

Market Cap
$182B
Large-cap
+190%
2016 — today
10-Year Price
+146%
2016 — today
52-Week Range
$82.56$130.59
Current $104.57· 46%

Abbott Laboratories (est. 1888) is a global healthcare enterprise operating through four primary divisions. Its Established Pharmaceutical Products segment provides generic medications for conditions ranging from hypertension and dyslipidemia to gynecological and gastrointestinal disorders. The Diagnostic Products division offers laboratory systems, molecular diagnostics, point-of-care testing, and informatics. Nutritional Products delivers formulations for pediatric and adult populations. Medical Devices focuses on cardiovascular, diabetes, and neuromodulation technologies.

Similar companies

Healthcare companies of comparable size to ABT
CompanyP/EDiv yield
NVONovo Nordisk A/S10.04.6%
PFEPfizer Inc.39.65.7%
DHRDanaher Corporation38.80.6%
GILDGilead Sciences, Inc.-52.42.0%
ISRGIntuitive Surgical, Inc.53.9—
VRTXVertex Pharmaceuticals Incorporated31.4—
AMGNAmgen Inc.28.62.2%
BMYBristol-Myers Squibb Company13.64.1%

Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.

Valuation in context

P/E ratio
38.7
Above average
Pricier than usual over the last 10 years
Sector median 25.2above sector
Dividend Yield
2.4%
Near historic high
Near historic highs — last 10 years
Sector median 1.8%above sector
Free · No credit card needed

Get alerted when ABT is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.